-
Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
02 May 2025 12:00 GMT
… for common diseases, like osteoarthritis. Symposium Title: High-Capacity … U.S. Food and Drug Administration and Advanced Therapy … study) for the treatment of knee osteoarthritis. To learn more … is also advancing the development of PCRX-201 (enekinragene …
-
Biden wanted Medicaid to pay for weight-loss drugs. Trump turned it back into an option.
01 May 2025 19:38 GMT
… high-priced medications for their residents.
The drugs, which … family history of premature heart disease, osteoarthritis, gallstones, age (men … , or discounts, with drug manufacturers, and by getting … Medicaid to cover obesity treatment services. The program …
-
Biosplice Announces First Patient Dosed in Phase 2 Trial of Cirtuvivint for Advanced Soft-Tissue Sarcomas
01 May 2025 10:00 GMT
… This Investigator Initiated Trial follows a preclinical collaboration … and treatment-resistant forms of the disease remain a … s drugs in clinical development include lorecivivint for knee osteoarthritis ( … growth, survival, and drug resistance. The compound …
-
$486 Billion Problem: Groundbreaking Study Could Slash Osteoarthritis Costs
01 May 2025 05:00 GMT
… the disease’s underlying biology and revealing hundreds of potential drug … targeted by approved drugs. This could enable existing medications approved for … to accelerating the development of effective treatments for osteoarthritis,” explains study leader …
-
Amanda Nelson Contributes to Landmark Osteoarthritis Study
01 May 2025 01:05 GMT
… study entitled, “Translational genomics of osteoarthritis in 1,962,069 individuals … reveal promising new directions for drug development and therapeutic intervention.
A key … the long-standing Johnston County Osteoarthritis Project (JoCoOA), which played a …
-
Strides strengthens anti-inflammatory portfolio with US FDA approval for celecoxib capsules 100 mg, 200 mg, & 400 mg
30 Apr 2025 13:26 GMT
… United States Food & Drug Administration (FDA).
The product is bioequivalent … population with effective, affordable treatment options. Celecoxib is a … associated with various conditions including osteoarthritis, rheumatoid arthritis, acute pain, …
-
Hundreds of genetic links to osteoarthritis unlocked
30 Apr 2025 11:53 GMT
… that, offering hope for drug development and personalised therapies.
By … 700 genetic disease-associated variants linked to osteoarthritis development. Eight biological … drugs approved for other conditions, which could expedite the development of treatments …
-
Beloved mum, 64, died at home after developing 'common infection'
30 Apr 2025 10:13 GMT
… pain with medication for years after an osteoarthritis diagnosis. In … , because had Debbie not developed that infection she wouldn… have developed over time because she has taken that medication … physical pain caused by osteoarthritis in her hip area, …
-
Pacira’s gene therapy shows sustained benefits in trial for knee osteoarthritis
29 Apr 2025 13:18 GMT
… osteoarthritis, as shown in a Phase I trial.
As part of the trial … .
The Phase I trial involved 72 subjects aged … and Knee Injury and Osteoarthritis Outcome scores.
The corticosteroid … of knee osteoarthritis without any serious treatment-emergent adverse …
-
iPSC Technology Overcomes Cell Therapy Manufacturing Hurdles
04 May 2025 00:48 GMT
… Therapeutics have developed the Cymerus … disease-modifying treatment for underserved diseases such as osteoarthritis … disease progression in osteoarthritis.
There's currently no disease-modifying osteoarthritis drug … Phase 3 osteoarthritis trial discussed. …